Abstract:Xin Zhao, 1, &ast Pingyuan Ge, 1, &ast Shaohua Lei, 1 Siqi Guo, 1 Peng Zhou, 1 Li Zhao, 1 Yiyu Qi, 1 Xiaotong Wei, 2 Weizhen Wu, 2 Ningjing Wang, 2 Rui Guo, 3 Nianyun Yang, 1 Qingqing Xiao, 1 Qichun Zhang, 1, 2 Huaxu Zhu 1 1 Department of Traditional Chinese Medicine Processing and Preparation, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, People's Republic of China; 2 Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China; 3 School of Medicine and Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Qichun Zhang; Huaxu Zhu, Email ; Introduction: Neuroinflammation is one of the major pathogeneses in Alzheimer's disease (AD) and mainly involves abnormal inflammatory activation of microglia by multiple pathological stimuli. The treatment of AD remains a major challenge due to the multifactorial characterization of AD and the inefficient ability of therapeutic drugs to permeate through the blood‒brain barrier (BBB). Accordingly, drug combination treatment and drug carrier delivery have become important therapeutic tools for the treatment of multifactorial diseases, especially AD. Methods: Inflammatory cytokine levels in microglia, including NO, TNF-α, IL-1β, IL-4, and IL-10, were detected. The Morris water maze and object location task were used to investigate the learning and memory functions of APP/PS1 mice in different treatment groups. The number of neurons and plasticity of synapses were evaluated by immunofluorescence double labelling. Additionally, the ratio of β-amyloid plaques and the number of activated microglia were evaluated by immunofluorescence staining. The concentrations of β-amyloid plaques and inflammatory factors in the hippocampus were determined by ELISA. Microglia-derived exosomes (Exos) were extracted and purified by size exclusion chromatography. The distribution of exosomes and drugs was investigated in vitro and in vivo. Results: Compared to single drug interventions, the combination of Ber and Pal (Ber/Pal) modulated microglial inflammatory cytokine levels. Ber/Pal promoted the recovery of learning and memory impairment in APP/PS1 mice. Immunofluorescence staining indicated that Ber/Pal restored neurons, inhibited Aβ plaque formation and microglial activation, and regulated the secretion of inflammatory factors. Exos promoted the accumulation of drugs in cells and tissues and improved the targeting of drugs across the BBB. Conclusion: Ber/Pal could offer a synergistic and more comprehensive therapeutic effect in AD. Additionally, the microglia-derived Exos-Ber/Pal delivery system promoted the targeting and permeation of drugs into the brain, suggesting a creative strategy for targeting AD therapy by regulating neuroinflammation in microglial cells. Keywords: Alzheimer's disease, neuroinflammation, phytoconstituents, drug combination, BBB permeability, exosomes Neuroinflammation, which has become the third major pathological feature in AD after β-amyloid (Aβ) deposition and neurofibrillary tangles, is an immune response activated by glial cells in the central nervous system (CNS), usually in response to stimuli such as nerve injury, Aβ plaques and tau neurofibrillary tangles or in response to autoimmunity. As the major inflammatory regulator in the CNS, microglia and their phenotypic modulation play a crucial role in regulating the progression of neurodegenerative diseases. 1 The phenotypic alternation of microglia mainly involves the M1 phenotype (proinflammatory) and the M2 phenotype (anti-inflammatory), and the release of inflammatory factors is an important physiological process for maintaining cerebral homeostasis. 2 Besides, a recent clinical epidemiological study revealed that the onset of neuroinflammation is associated with increased brain deposition of Aβ and tau, suggesting that the onset of neuroinflammation before the onset of cognitive symptoms may serve as an adaptive mechanism to prevent the accumulation of Aβ and tau proteins. 3 Accordingly, targeting neuroinflammation may provide a novel and promising therapy for AD. Berberine (Ber) and palmatine (Pal) are isoquinoline alkaloids mainly isolated from Rhizoma Coptidis and have exhibited extensive pharmacological effects encompassing antioxidant, anti-inflammatory, antitumour, and neuroprotective effects. -Abstract Truncated-

Synergistic Inhibition on Acetylcholinesterase by the Combination of Berberine and Palmatine Originally Isolated from Chinese Medicinal Herbs

Berberine and palmatine, acting as allosteric potential ligands of α7 nAChR, synergistically regulate inflammation and phagocytosis of microglial cells

Synergic Effects of Berberine and Curcumin on Improving Cognitive Function in an Alzheimer’s Disease Mouse Model

Berberine: a Potential Multipotent Natural Product to Combat Alzheimer's Disease.

Pharmacological Action of Multi-Target-Directed Proberberine on Anti-Alzheimer's Disease

Pharmacological Action of Multi-Target-Directed -Proberberine on AntiAlzheimer's Disease

Acetylcholinesterase inhibition of Alzheimer’s disease: identification of potential phytochemicals and designing more effective derivatives to manage disease condition

Anti-Cholinesterase Combination Drug Therapy as a Potential Treatment for Alzheimer’s Disease

An Exosome-Based Therapeutic Strategy Targeting Neuroinflammation in Alzheimer's Disease with Berberine and Palmatine

Inhibition of Cholinesterase Activity and Amyloid Aggregation by Berberine-Phenyl-benzoheterocyclic and Tacrine-Phenyl-benzoheterocyclic Hybrids.

Design, Synthesis and Evaluation of Rivastigmine and Curcumin Hybrids As Site-Activated Multitarget-Directed Ligands for Alzheimer's Disease Therapy.

Evaluation of Anti-Cholinesterase and Anti-Inflammation Activities of Berberine Derivatives

Benzenediol-berberine Hybrids: Multifunctional Agents for Alzheimer's Disease.

Synergistic Effects of Curcumin and Piperine as Potent Acetylcholine and Amyloidogenic Inhibitors With Significant Neuroprotective Activity in SH-SY5Y Cells via Computational Molecular Modeling and in vitro Assay

Combining In Silico and In Vitro Studies to Evaluate the Acetylcholinesterase Inhibitory Profile of Different Accessions and the Biomarker Triterpenes of Centella asiatica

Cholinesterase Inhibitory and In Silic o Toxicity Assessment of Thirty-Four Isoquinoline Alkaloids - Berberine as the Lead Compound

Exploring Medicinal Herbs' Therapeutic Potential and Molecular Docking Analysis for Compounds as Potential Inhibitors of Human Acetylcholinesterase in Alzheimer's Disease Treatment

Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential

Synthesis and evaluation of 6-substituted 3-arylcoumarin derivatives as multifunctional acetylcholinesterase/monoamine oxidase B dual inhibitors for the treatment of Alzheimer’s disease

Synthesis and Biological Evaluation of Berberine–thiophenyl Hybrids As Multi-Functional Agents: Inhibition of Acetylcholinesterase, Butyrylcholinesterase, and Aβ Aggregation and Antioxidant Activity